A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs
文献类型：期刊论文
| 作者 | Lu, S.9 ; Zhang, Y.10; Zhang, G.11; Zhou, J.12; Cang, S.1; Cheng, Y.13; Wu, G.14; Cao, P.15; Lv, D.16; Jian, H.9
|
| 刊名 | JOURNAL OF THORACIC ONCOLOGY
 |
| 出版日期 | 2022-09-01 |
| 卷号 | 17 |
| 关键词 | third-generation EGFR-TKI befotertinib T790M |
| ISSN号 | 1556-0864 |
| WOS研究方向 | Oncology ; Respiratory System |
| 语种 | 英语 |
| WOS记录号 | WOS:000858678101268 |
| 出版者 | ELSEVIER SCIENCE INC |
| 源URL | [http://ir.hfcas.ac.cn:8080/handle/334002/129941]  |
| 专题 | 中国科学院合肥物质科学研究院 |
| 作者单位 | 1.Henan Prov Peoples Hosp, Zhengzhou, Peoples R China 2.Hebei Univ, Affiliated Hosp, Baoding, Peoples R China 3.Chongqing Univ, Chongqing Canc Hosp, Canc Hosp, Chongqing, Peoples R China 4.Nanjing Univ, Sch Med, Jinling Hosp, Nanjing, Peoples R China 5.Liaoning Canc Hosp & Inst, Shenyang, Peoples R China 6.China Med Univ, Shengjing Hosp, Shenyang, Peoples R China 7.Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Beijing, Peoples R China 8.Chengde Med Coll, Affiliated Hosp, Chengde, Peoples R China 9.Shanghai Chest Hosp, Shanghai, Peoples R China 10.Univ Chinese Acad Sci, Canc Hosp, Zhejiang Canc Hosp, Hangzhou, Peoples R China |
| 推荐引用方式 GB/T 7714 | Lu, S.,Zhang, Y.,Zhang, G.,et al. A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs[J]. JOURNAL OF THORACIC ONCOLOGY,2022,17. |
| APA | Lu, S..,Zhang, Y..,Zhang, G..,Zhou, J..,Cang, S..,...&Zhang, S..(2022).A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs.JOURNAL OF THORACIC ONCOLOGY,17. |
| MLA | Lu, S.,et al."A Phase 2 Study of Befotertinib in Patients with EGFR T790M Mutated NSCLC after Prior EGFR TKIs".JOURNAL OF THORACIC ONCOLOGY 17(2022). |
入库方式： OAI收割
来源：合肥物质科学研究院
浏览0
下载0
收藏0
其他版本
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。